Home » Authors » Anette Breindl

Articles by Anette Breindl

AIDS Vaccine Seems Closer, Albeit Still Elusive for Now

Dec. 1, 2009

By Anette Breindl

H5N1 Flu Can't Easily Get There from Here: Pandemic Odds Low

Nov. 30, 2009

By Anette Breindl

For IDH1, Change in Mechanism Opens Up Targeting Possibilities

Nov. 24, 2009

By Anette Breindl

'Co-Clinical Trials' Are Urged at Molecular Targets Meeting

Nov. 18, 2009

By Anette Breindl

Study Links Oxidative Damage to BAK, and to Hearing Loss

Nov. 16, 2009

By Anette Breindl

Method Predicts New Uses for, Side Effects of Known Drugs

Nov. 13, 2009

By Anette Breindl

Peptide Brings Transcription Factors Into Druggable Realm

Nov. 12, 2009

By Anette Breindl

Gene Therapy Successful at Treating X-Linked ALD

Nov. 6, 2009

By Anette Breindl

Resolvin Fights Inflammation While Preservin' Immunity

Nov. 4, 2009

By Anette Breindl

New Compound 'Preempts Resistance' of BCR-ABL

Nov. 3, 2009

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...